ArticleAesthetic plastic surgery2026
Current Trends in Revision Surgery After Breast Reconstruction in China: Insights from a Nationwide Cross-Sectional Survey.
Article in Aesthetic plastic surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Experimental and Clinical Evaluation of Optimized Composite Collagen-Crosslinked Hyaluronic Acid Filler for Infraorbital Rejuvenation.Aesthetic plastic surgery · 2026Trial
- Beyond Suture Material: Integrating Tension-Line Orientation, Flap Redraping and Progressive Tension Sutures for Optimal Scar Suppression.Aesthetic plastic surgery · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
introductionRevision surgery is an integral component of post-mastectomy breast reconstruction, aimed at enhancing breast aesthetics and improving patient satisfaction. While developed countries have established high rates of revision surgery, its implementation in China remains limited. We aimed to evaluate the current practices and challenges of revision surgery in Mainland China using a nationwide cross-sectional survey.
methodsA nationwide questionnaire authorized by the Chinese Anti-Cancer Association and related committees was distributed to 215 hospitals in China performing over 200 annual breast cancer surgeries, with 198 hospitals completed the survey. Data on nipple-areola complex reconstruction (NAR), autologous fat grafting (AFG), and contralateral breast symmetry surgery were collected and analyzed.
resultsOf the 198 surveyed hospitals, 23.2% performed NAR, 17.2% conducted AFG, and 26.8% carried out contralateral breast symmetry surgery, with only 6.6% providing all three. (1) NAR: Both the time intervals between primary breast reconstruction and NAR and the diverse techniques of NAR were to note. The use of autologous or allogenic implants has proven to improve long-term nipple projection (median nipple shrinkage rate 5.5% vs 30%; P < 0.001), but its usage was still limited. (2) AFG: AFG has wide application in breast reconstruction, with the most common use remaining the correction of deformities after lumpectomy (28/34, 82.4%) or breast reconstruction after mastectomy (21/34, 61.8%). (3) Contralateral breast symmetry surgery: Contralateral breast symmetry surgery was widely accepted by patients, and a simultaneous procedure was more favored (median 80% vs 20%; P < 0.001).
conclusionThe implementation of revision surgery in China remains insufficient and unevenly distributed. Targeted efforts to expand specialized training, especially in plastic surgery, improve resource allocation, and adopt advanced techniques are essential. LEVEL OF EVIDENCE IV: This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.